One animal model study also found ezetimibe caused dose-dependent reductions in biliary cholesterol levels, and prevented gallstone formation [58]; however, mice’s lack of hepatic NPC1L1 should be take into consideration. The gene discussed is NPC1L1; the disease is gallstones.